Answers are grounded in this paper and cite their sources.
From olmesartan-induced enteropathy to small CD4(+) T-cell intestinal lymphoproliferation, the spectrum of non-celiac villous atrophy has recently been largely extended. Precise characterization of the different types of non-celiac enteropathy with villous atrophy is necessary to avoid misdiagnosis, to identify a causal mechanism and propound appropriate therapeutic strategies. This paper discusses how to use the different diagnostic tools to address diagnostic criteria, citing the examples of recent new cases of non-celiac enteropathy with intestinal villous atrophy.
No takes yet. Share an insight, caveat, or question.
Malamut et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: